Integrated double redo percutaneous valve replacement: simultaneous transcatheter aortic and mitral valve management
TDVI appears to be a safe and effective alternative to surgical redo double-valve replacement for selected patients. Our findings support the feasibility of TDVI with excellent early outcomes. Further prospective multicentre studies with larger cohorts are needed to validate the long-term effects and to establish TDVI as a guideline consideration.
Authors
- Jörg Kempfert (ORCID: https://orcid.org/0000-0002-2009-6375)
- Chong Bin Lee (ORCID: https://orcid.org/0009-0009-0702-6194)
- Hristian Hinkov (ORCID: https://orcid.org/0000-0002-9602-2794)
- Volkmar Falk (ORCID: https://orcid.org/0000-0002-7911-8620)
- Henryk Dreger (ORCID: https://orcid.org/0000-0003-1909-4329)
- Dustin Greve (ORCID: https://orcid.org/0000-0001-6241-6544)
- Stephan Jacobs (ORCID: https://orcid.org/0000-0001-7353-1855)
- Axel Unbehaun (ORCID: https://orcid.org/0000-0003-2851-695X)
- Christoph A. Klein (ORCID: https://orcid.org/0000-0001-7128-1725)
- Marian Kukucka (ORCID: https://orcid.org/0000-0001-6201-1600)
Institutions
- ETH Zurich (CH)
- Humboldt-Universität zu Berlin (DE)
- Deutsches Herzzentrum der Charité (DE)
- German Centre for Cardiovascular Research (DE)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- European Journal of Cardio-Thoracic Surgery
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1093/ejcts/ezaf023
- Citations
- 3
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.16